Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Tumor mutation burden testing: a survey of the International Quality Network for Pathology (IQN Path).

Virchows Archiv : an international journal of pathology - 1 Dec 2021

Fenizia Francesca, Wolstenholme Nicola, Fairley Jennifer A, Rouleau Etienne, Cheetham Melanie H, Horan Martin P, Torlakovic Emina, Besse Benjamin, Al Dieri Raed, Tiniakos Dina G, Deans Zandra C, Patton Simon J, Normanno Nicola

Abstract excerpt

While tumour mutation burden (TMB) is emerging as a possible biomarker for immune-checkpoint inhibitors (ICI), methods for testing have not been standardised as yet. In April 2019, the International Quality Network for Pathology (IQN Path) launched a survey to assess the current practice of TMB testing. Of the 127 laboratories that replied, 69 (54.3%) had already introduced TMB analysis for research purposes...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Australia
Share to Canada

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Clinical Decision-Making

Share to Health Care Surveys

Share to Immune Checkpoint Inhibitors

Share to INDEL Mutation

Share to Observer Variation

Share to Precision Medicine

Source

Open in PubMed Open full text

Identifiers

PMID: 33856555
DOI: 10.1007/s00428-021-03093-7
PMCID: PMC8724102

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Tumor mutation burden testing: a survey of the International Quality Network for Pathology (IQN Path).PMID 33856555Read ↗

Harmonization of tumor mutation burden testing with comprehensive genomic profiling assays: an IQN Path initiative.Semantic proximity Read ↗

External quality assessment (EQA) for tumor mutational burden: results of an international IQN path feasibility pilot scheme.Semantic proximity Read ↗

Discordance in Tumor Mutation Burden from Blood and Tissue Affects Association with Response to Immune Checkpoint Inhibition in Real-World Settings.Semantic proximity Read ↗

Harmonization and Standardization of Panel-Based Tumor Mutational Burden Measurement: Real-World Results and Recommendations of the Quality in Pathology Study.Semantic proximity Read ↗

Tumor mutational burden assessment and standardized bioinformatics approach using custom NGS panels in clinical routine.Semantic proximity Read ↗

Open the Technical Black Box of Tumor Mutational Burden (TMB): Factors Affecting Harmonization and Standardization of Panel-Based TMB.Semantic proximity Read ↗

Implementing tumor mutational burden (TMB) analysis in routine diagnostics—a primer for molecular pathologists and cliniciansSemantic proximity Read ↗

Tumour mutational burden: clinical utility, challenges and emerging improvements.Semantic proximity Read ↗

Tumour mutational burden: an overview for pathologists.Semantic proximity Read ↗

Expert consensus on the detection and clinical application of tumor mutational burden.Semantic proximity Read ↗

A Systematic Review and Meta-Analysis of the Impact of Tumour Mutation Burden on Survival Outcomes in Solid Tumours.Semantic proximity Read ↗

Methods of measurement for tumor mutational burden in tumor tissueSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.